1. Introduction {#sec1}
===============

Mitochondria are the primary source of reactive oxygen species (ROS), including superoxide radicals (O~2~^**.**-^), in cells of aerobic organisms. Almost all mitochondrial oxygen consumption is efficiently coupled to the production of ATP; however, a small percentage (\<0.1%) of molecular oxygen is reduced by electrons that mechanistically leak in mitochondria and subsequently produce toxic ROS \[[@bib1]\]. Superoxide dismutase (SOD) is an important enzyme that catalytically removes O~2~^**.**-^ and protects organisms from the oxidative damage during aging \[[@bib2],[@bib3]\]. However, SOD results in further production of hydrogen peroxide (H~2~O~2~), which is a type of ROS, in cells by the disproportionation reaction \[[@bib2],[@bib4]\]. Therefore, the activation of SOD in cells is vital and critically balanced for controlling intracellular ROS.

In the *Caenorhabditis elegans* (*C. elegans*) genome, the *sod-1* to *-5* genes encode distinct SOD isozymes; *sod-1* and *-5* encode Cu/Zn SODs, *sod-2* and *-3* encode mitochondrial Mn SODs, and *sod-4* encodes the homolog of an extracellular Cu/Zn SOD in mammals \[[@bib5], [@bib6], [@bib7], [@bib8], [@bib9]\]. Disruption of the expression of *sod* genes increases mitochondrial O~2~^**.**-^ levels and directly affects the lifespan of *C. elegans* \[[@bib9],[@bib10]\]. Indeed, experimental estimates of the effect of each *sod* gene on lifespan have varied because the expression of these *sod* genes is changed in a mutually compensatory manner to maintain catalytic function in cells \[[@bib9], [@bib10], [@bib11], [@bib12]\].

We previously revealed the compensatory expression of *sod-5* in *sod-1* deletion mutants and its regulation via an insulin/insulin-like growth factor-1 (ins/IGF-1) signaling pathway \[[@bib9]\]. The mammalian forkhead transcription factor FOXO ortholog DAF-16 functions downstream of the ins/IGF-1 signaling pathway and regulates the expression of target genes such as *sod-3* and *-5* in *C. elegans*. In fact, the consensus sequence of the DAF-16 binding element (DBE) is present in the promoter regions of *sod-2*, *-3* and *-5* genes \[[@bib9],[@bib13], [@bib14], [@bib15]\]. In addition to DBE, a binding site for the mammalian NF-E2-related factor (Nrf) ortholog SKN-1, which is upregulated by the p38 mitogen-activated protein kinase (MAPK) signaling pathway, is found in the promoter regions of all *sod* genes \[[@bib15], [@bib16], [@bib17], [@bib18]\]. Thus, recent studies have shown that the ins/IGF-1 and other signaling pathways including the p38 MAPK cascade, are associated with the regulation of SOD expression in response to oxidative stress and immunity during normal aging in *C. elegans*. However, this interaction between the ins/IGF-1 and p38 MAPK signaling pathways for the compensatory expression of *sod* genes has been only partly understood except for the participation of several insulin peptides \[[@bib19], [@bib20], [@bib21]\]. Determining the molecular mechanisms of this interaction could contribute to the control of ROS levels in aged cells and animals by regulating the expression of antioxidant genes such as *sod* genes. In this study, we examined whether *sod-1* expression levels were also increased in a *sod-5* deletion mutant, and attempted to clarify whether the mammalian MAPK kinase (MAPKK) homolog SEK-1 and downstream transcription factor SKN-1, which are predicted to regulate the transcription of all *sod* genes, are required for modulating their compensatory expression. Consequently, we report the molecular mechanisms for fine-tuning the expression of *sod* genes via switching between the ins/IGF-1 and p38 MAPK signalings by an insulin peptide \[[@bib15],[@bib19]\].

2. Materials and methods {#sec2}
========================

2.1. Nematode strains and maintenance {#sec2.1}
-------------------------------------

The wild-type N2 strain var. Bristol and other strains of *C. elegans*, namely *daf-16(mgDf50)* and *sek-1(km4),* were obtained from the Caenorhabditis Genetics Center at the University of Minnesota (Minneapolis, MN). The *daf-16(mgDf50)* strain has a deficiency of the *daf-16* gene-coding region including almost all *daf-16* transcripts alternatively spliced \[[@bib22]\]. Exons 4--6 of *sek-1* gene are deleted in the *sek-1(km4)* strain \[[@bib23]\]. The *sod-1(tm776)*, *sod-5(tm1146)* and *ins-5(tm2560)* deletion mutants were supplied by the National Bioresource Project for the Experimental Animal "Nematode *C. elegans*" \[[@bib9]\]. A mutant strain, *sod-1(tm776)*;*sod-5(tm1146)*, was obtained from Dr. T. Sakamoto of Kitasato University. In addition, we isolated *sod-1(tm776);daf-16(mgDf50)* and *sod-1(tm776);sek-1(km4)* double mutants by outbreeding. Worms were grown at 20 °C on nematode growth medium (NGM) agar plates with *Escherichia coli* (*E. coli*) OP50, a uracil-requiring strain \[[@bib24]\].

2.2. Measurement of lifespan {#sec2.2}
----------------------------

The lifespan of hermaphrodites at 20 °C was measured using 100 worms per trial in at least three independent experiments \[[@bib24]\]. To prevent reproduction, 5-fluoro-2′-deoxyuridine, FUdR (Wako Pure Chemical Industries, Ltd., Osaka, Japan) was added to the NGM agar plate to a final concentration of 40 μM after the animals had reached adulthood. Means were compared using Student\'s *t*-test. Data are expressed as means ± standard deviation (SD). A two-tailed *p*-value of \<0.05 was considered statistically significant.

2.3. Real-time PCR analysis of gene expression {#sec2.3}
----------------------------------------------

Poly(A)^+^ RNA from 5-day-old animals was prepared for reverse transcription PCR (RT-PCR), and complimentary DNA (cDNA) was synthesized as described previously \[[@bib24]\]. Quantitative measurement using a TaqMan gene expression assay in 5-day-old animals was performed using a 7500 Fast Real-Time PCR System (Applied Biosystems by Thermo Fisher Scientific, Waltham, MA). The results were normalized to the transcript level of *act-4* using the wild-type strain as a control. The means of at least three measurements were compared using Student\'s *t*-test. Data are expressed as means ± standard error of the mean (SEM). A two-tailed *p*-value of \<0.05 was considered statistically significant.

2.4. Measurement of mitochondrial and sub-mitochondrial particle O~2~^**.**-^ production {#sec2.4}
----------------------------------------------------------------------------------------

To isolate the mitochondrial fraction, 5-day-old animals were washed with S-buffer and mannitol-sucrose buffer and homogenized with 60 strokes of a Teflon homogenizer, Eyela Mazela Z (Tokyo Rikakikai Co., Ltd., Tokyo, Japan) at 1300 rpm on ice. The intact mitochondrial fraction was isolated as described previously \[[@bib9],[@bib26]\]. After storage at −80 °C for 2 days, the mitochondrial fraction was sonicated using an ultrasonic homogenizer UH-50 (SMT Co., Ltd., Tokyo, Japan) to isolate the sub-mitochondrial particle (SMP) fraction, which is the characteristic mitochondrial inner membrane fragments reformed into inside-out vesicles. The SMP fraction includes little or no mitochondrial matrix, which contains soluble enzymes such as Mn SODs \[[@bib4],[@bib25]\]. The SMP fraction was resuspended in Tris-EDTA (TE) buffer \[[@bib26]\]. The protein content of each fraction was determined using a BCA Protein Assay Kit (Pierce Biotechnology, Inc., Rockford, IL). Mitochondrial and SMP O~2~^**.**-^ production was measured using a specific chemiluminescent probe, 2-methyl-6-p-methoxyphenylethynyl-imidazopyrazinone, MPEC (Atto Co., Tokyo, Japan), in an AccuFLEX Lumi 400 luminometer (Aloka Co., Ltd., Tokyo, Japan) \[[@bib9],[@bib26],[@bib27]\].

2.5. Subcellular localization of DAF-16::GFP {#sec2.5}
--------------------------------------------

To detect the expression and subcellular localization of DAF-16, we used a pGP30 plasmid, which includes green fluorescent protein (GFP) gene fused to the *daf-16a2* gene containing a 6-kb upstream region. pGP30 was microinjected into the gonads of several strains at 100 ng/μL with pRF4 containing the *rol-6(su1006)* gene \[[@bib9]\]. DAF-16:GFP localization in the nuclei of 5-day-old animals was observed using a fluorescence microscope with a digital imaging system BX51TRF (Olympus Co., Tokyo, Japan).

3. Results {#sec3}
==========

3.1. Lifespan and compensatory expression of other sod genes in the sod-5 mutant {#sec3.1}
--------------------------------------------------------------------------------

Means and maximum lifespans of the *sod-5* mutant of *C. elegans* were moderately decreased compared with the wild-type strain, and those of the *sod-1;sod-5* mutant was further decreased ([Fig. 1](#fig1){ref-type="fig"}a). The mRNA levels of *sod-1* to *-4* genes were enhanced in the *sod-5* mutant, but the compensatory expression of other *sod* genes was diminished in the *sod-1;sod-5* mutant ([Fig. 1](#fig1){ref-type="fig"}b). These results show that defects in both *sod-1* and *-5* have more deleterious effects on lifespan compared with the *sod-5* mutant.Fig. 1(A) Lifespan of the *sod-5*-related mutants at 20 °C. Mean lifespan ±SD was as follows; 29.8 ± 9.1 days in the wild-type strain, 26.4 ± 7.0 days in the *sod-5* mutant, and 23.4 ± 7.9 days in the *sod-1;sod-5* mutant. The mean lifespans of the *sod-5* and *sod-1;sod-5* mutants were shorter compared with that of the wild-type strain (*P* \< 0.05 and \< 0.0001, respectively). Means were conducted by Student\'s *t*-test. (B) Real-time PCR data of *sod* genes expression in the strains. Data are shown as means ± SEM. Means were compared by Student\'s *t*-test (\**P* \< 0.05, \*\**P* \< 0.001). (C) O~2~^**.**-^ production in mitochondria, cytosol and SMP of the strains. Open, shaded and closed columns indicate O~2~^**.**-^ levels of the wild-type strain, *sod-5* and *sod-1;sod-5* mutants, respectively. Data are shown as means ± SD. Means were compared by Student\'s *t*-test (\*\*\**P* \< 0.0001).Fig. 1

3.2. Changes in the mitochondrial and SMP O~2~^**.**-^ levels in the sod-5 mutant {#sec3.2}
---------------------------------------------------------------------------------

We found significant increases in the O~2~^**.**-^ levels of mitochondria but not SMP fraction, which includes little or no mitochondrial matrix and the soluble enzymes such as Mn SODs \[[@bib25]\], in the *sod-5* and *sod-1;sod-5* mutants compared with the wild-type strain. Generally, the O~2~^**.**-^ levels in SMP are unaffected by the Mn SODs and indicating a net side-product capable of activating the electron transport chain (ETC) and oxidative phosphorylation (OxPhos) in the SMP fraction itself. That is, the increases in mitochondrial O~2~^**.**-^ levels in the *sod-5* and *sod-1:sod-5* mutants involved mainly the deficient activity of mitochondrial SODs, which include not only Mn SODs in the matrix but also Cu/Zn SODs in the mitochondrial intermembrane space \[[@bib9],[@bib25]\]. In contrast, cytosolic O~2~^**.**-^ levels were increased in the *sod-1;sod-5* mutant, but not in the *sod-5* mutant, compared with the wild-type strain ([Fig. 1](#fig1){ref-type="fig"}c). This shows that deletion of both *sod-1* and *-5* does not affect the net production of mitochondrial O~2~^**.**-^, however, it results in the impaired removal of O~2~^**.**-^ from mitochondria by SODs. Probably, the compensatory expression of other *sod* genes in the *sod-5* mutant contributed to the cytosolic decrease of O~2~^**.**-^ levels in cytoplasm and prevented mitochondrial O~2~^**.**-^ leakage ([Fig. 1](#fig1){ref-type="fig"}b and c).

3.3. Predicted binding sites of the DAF-16 and SKN-1 transcription factors {#sec3.3}
--------------------------------------------------------------------------

According to previous reports, each of *sod-2*, *-3* and *-*5 has one or two predicted DBEs, and all *sod* genes have one or two predicted SKN-1 binding sites in their promoter regions \[[@bib9],[@bib13], [@bib14], [@bib15], [@bib16], [@bib17]\]. Here, we found two novel predicted SKN-1 binding sites in the upstream region of *sod-4* gene and a novel predicted DBE in the upstream region of *sod-2* gene. As a result, at least one predicted DAF-16 and/or SKN-1 binding site is present in the promoter regions of all *sod* genes ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Putative DBE sequences and SKN-1 binding sites located upstream of the first exon of the *sod* genes. Lower and upper case letters show parts of the promoter and exon regions in the *sod* genes, respectively. The DBE and SKN-1 binding sites are represented as closed and shaded boxes, respectively.Fig. 2

3.4. Changes in lifespan and compensatory expression of sod genes under DAF-16 activation {#sec3.4}
-----------------------------------------------------------------------------------------

Based on the predicted binding sites, we examined the effects of the transcription factors DAF-16 and SKN-1, which are involved in the compensatory expression of *sod* genes, on the lifespan of *C. elegans*. As a result, we found that DAF-16 and SKN-1 had different effects on the lifespan of *sod-1* mutant. Deletion of *daf-16* further shortened lifespan, however, deletion of *sek-1*, which is associated with the activation of SKN-1 through the p38 MAPK signaling \[[@bib17]\], had almost no effect on the lifespan of *sod-1* mutant ([Fig. 3](#fig3){ref-type="fig"}a). According to our previous data, intrinsic DAF-16 activation in the *sod-1* mutants leads to the compensatory expression of *sod-5* \[[@bib9]\]. We confirmed the compensatory expression of *sod-3* and *-5* in the *sek-1* mutant, but this effect was suppressed in the *sod-1;sek-1* mutant ([Fig. 3](#fig3){ref-type="fig"}b).Fig. 3(A) Effects of impaired signaling on lifespan at 20 °C in the *sod-1* mutant. Mean lifespan ±SD was as follows; 29.8 ± 7.7 days in the wild-type strain, 25.1 ± 6.8 days in the *sod-1* mutant, and 19.9 ± 4.2 days in the *sod-1;daf-16* mutant. Mean lifespan ±SD was as follows; 29.9 ± 7.3 days in the wild-type strain, 19.5 ± 17.0 days in the *sek-1* mutant, and 19.7 ± 13.6 days in the *sod-1;sek-1* mutant. Mean lifespan was different between the *sod-1* and *sod-1;daf-16* mutants (*P* \< 0.0001), but not between the *sek-1* and *sod-1;sek-1* mutants. Means were compared by Student\'s *t*-test was performed. (B) Real-time PCR data of the *sod* genes expression in the strains. Data shown represent the means ± SEM. Means were compared by Student\'s *t*-test (\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001). (C) O~2~^**.**-^ production in mitochondria, cytosol and SMP of the strains. Open, shaded and closed columns indicate O~2~^**.**-^ levels of the wild-type strain, *sek-1* and *sod-1;sek-1* mutants, respectively. Data are shown as means ± SD. Means were compared by Student\'s *t*-test (\*\*\**P* \< 0.0001).Fig. 3

3.5. Changes in mitochondrial and SMP O~2~^**.**-^ levels under DAF-16 activation {#sec3.5}
---------------------------------------------------------------------------------

We confirmed significant increases in the O~2~^**.**-^ levels of mitochondria, but not in the SMP fraction, in the *sek-1* and *sod-1;sek-1* mutants compared with the wild-type strain. Likewise, cytosolic O~2~^**.**-^ levels were higher in the *sek-1* and *sod-1;sek-1* mutants than in the wild-type strain ([Fig. 3](#fig3){ref-type="fig"}c). These findings show that deletion of both *sek-1* and *sod-*1 has almost no effect on the net production levels of mitochondrial O~2~^**.**-^, however, it decreases remarkably the catalytic removal of mitochondrial O~2~^**.**-^ in the *sod-1;sek-1* mutant.

3.6. Reduction of DAF-16::GFP nuclear translocalization via p38 MAPK signaling {#sec3.6}
------------------------------------------------------------------------------

In 5-day-old wild-type animals, almost all DAF-16a2 protein was observed in the cytoplasm and not in the nucleus ([Fig. 4](#fig4){ref-type="fig"}a). However, in the 5-day-old *sod-1*, *sek-1* and *sod-1;sek-1* mutant animals, most DAF-16 protein was translocated into the nucleus ([Fig. 4](#fig4){ref-type="fig"}b--d).Fig. 4DAF-16a2:GFP localization in the (A) wild-type strain, (B) *sod-1* mutant, (C) *sek-1* mutant and (D) *sod-1;sek-1* mutant. (E) Left panel indicates a partial loss of *ins-5* gene expression in the *sek-1* deletion mutants. The predicted SKN-1 binding site was located 84 bp upstream of the first exon in *ins-5* (data not shown). Right panel indicates the real-time PCR data of *sod-3* and *-5* in the *ins-5* mutant. Data shown represent the means ± SEM. Means were compared by Student\'s *t*-test (\**P* \< 0.05, \*\**P* \< 0.0005, \*\*\**P* \< 0.0001). (F) Schematic diagram of *sod* gene regulation via the ins/IGF-1 and p38 MAPK signaling pathways.Fig. 4

3.7. Decreased expression of ins-5 gene with impaired p38 MAPK signaling {#sec3.7}
------------------------------------------------------------------------

The mRNA levels of a gene encoding an insulin peptide, *ins-5*, were decreased in the *sek-1* mutants compared with the wild-type strain ([Fig. 4](#fig4){ref-type="fig"}e). In the promoter region of *ins-5*, a SKN-1 binding site is located at 84 base pairs (bp) upstream of the first exon \[[@bib18]\]. These findings support the view that *ins-5* is a target gene of SKN-1 and its expression is upregulated via the p38 MAPK signaling.

4. Discussion {#sec4}
=============

We previously reported that the compensatory expression of *sod-5*, which encodes a Cu/Zn SOD, in *sod-1* mutants of *C. elegans* is regulated through the ins/IGF-1 signaling \[[@bib9]\]. Expression of *sod-1* and *-5*, which encode distinct Cu/Zn SOD isozymes, is tightly controlled and localized in the cytoplasm, lysosomes and mitochondrial intermembrane space \[[@bib9],[@bib25]\]. However, it is unclear whether the compensatory expression of other *sod* genes likewise occurs in a s*od-5* mutant. Here, we showed that several-fold higher expression of not only *sod-1* encoding another Cu/Zn SOD isozyme, but also *sod-2* and *-3* encoding Mn SOD isozymes, and the *sod-4* encoding an extracellular Cu/Zn SOD was induced in the *sod-5* mutant. Despite the low expression levels of *sod-5* in the wild-type strain \[[@bib9]\], its transcriptional disruption was remarkably compensated for other *sod* genes. Therefore, we inferred that this molecular compensation was responsible for the only slight decrease in lifespan of the *sod-5* mutant compared with the wild-type strain (but not the *sod-1* mutants). The compensatory expression in the *sod-5* and *sod-1;sod-5* mutants did not affect net mitochondrial O~2~^**.**-^ production, while it increased mitochondrial O~2~^**.**-^ levels compared with the wild-type strain. These results indicate that the compensatory expression of other *sod* genes plays a role in the maintenance of longevity in the mutants through the removal of intracellular ROS including mitochondrial O~2~^**.**-^ in the mutants; however, lifespan does not completely recover to that of the wild-type strain.

Both *sod-3* and *-5* are regulated via the ins/IGF-1 signaling pathway, which is associated with longevity and stress resistance in *C. elegans* \[[@bib9],[@bib14]\]. DAF-16 is activated downstream of ins/IGF-1 signaling. We discovered putative DBE sequences, which the DAF-16 transcription factor binds to, in the promoter regions of *sod-2*, *-3* and *-5*; however, the two DBE sequences in the promoter region of *sod-2* do not seem to function according to previous studies using a *daf-16* null mutant \[[@bib9],[@bib14],[@bib15]\]. SKN-1 also has putative binding sites in the promoter regions of all *sod* genes, and is associated with longevity through the regulation of intracellular ROS levels during aging and caloric restriction in *C. elegans* \[[@bib15],[@bib16],[@bib18],[@bib28]\]. We propose that *sod-2* expression is predominantly upregulated by the SKN-1 transcription factor, and it is also associated with longevity in *C. elegans* under stressful intracellular conditions in which *sod-1* and *-5* are both deleted. In contrast, *sod-3* and *-5* expression is mainly upregulated by the DAF-16 transcription factor in response to reduced ins/IGF-1 signaling under stressful condition \[[@bib16],[@bib26]\].

The lifespans in the *sod-1* mutants were shortened compared with the wild-type strain \[[@bib9],[@bib10]\]. This effect was enhanced by dysfunction of DAF-16; however, a deficiency of the p38 MAPK signaling had no effect on lifespan. In the *sod-1* mutant, DAF-16 targets such as *sod-3* and *-5* play an important role in the maintenance of lifespan \[[@bib9]\]. These findings indicate that *sod-1* expression requires p38 MAPK signaling, and is almost entirely upregulated by downstream SKN-1 via a DAF-16-independent pathway. According to previous reports, the MAPK signaling cascade extends lifespan through the nuclear localization of SKN--I and downregulation of the ins/IGF-1 signaling during aging \[[@bib17],[@bib19],[@bib20]\]. SKN-1 activated by its nuclear accumulation induces the transcriptional downregulation of insulin-like peptide genes, such as *ins-7* and *-39*, and the consequent downregulation of the ins/IGF-1 signaling \[[@bib20],[@bib21]\]. The *C. elegans* genome encodes 40 insulin-like peptides, which play distinct roles as agonists or antagonists of the ins/IGF-1-like receptor DAF-2 \[[@bib29]\]. Furthermore, we found that the insulin peptide gene, *ins-5*, which has a SKN-1 binding site in its promoter region, functions as a putative agonist of DAF-2, at least in part, and is transcriptionally regulated via the p38 MAPK signaling \[[@bib29]\]. Therefore, these results are consistent with the nuclear localization of DAF-16:GFP and the higher expression levels of the DAF-16 targets in the *sek-1* mutant.

In addition to *sod-1*, we found that *sod-2* and *-4* are transcriptionally regulated as targets of SKN-1, which is a downstream component of the p38 MAPK signaling. A deficiency of the p38 MAPK signaling leads to the decreased expression of *sod-1*, *-2* and *-4*, and instead, *sod-3* and *-5* expression is activated by the nuclear localization of DAF-16 under inactive ins/IGF-1 signaling. Unexpectedly, a simultaneous deficiency of SEK-1 in the *sod-1* mutant did not lead to increased expression of *sod-3* and *-5* despite the nuclear localization of DAF-16. The reduced expression of these DAF-16 target *sod* genes may be associated with damage to transcription factors as a result of higher levels of intracellular oxidative stress due to increased levels of mitochondrial O~2~^**.**-^. Otherwise, other DAF-16 isoforms may have a role in the transcriptional regulation of target *sod* genes under more stressful conditions. In this study, we observed the subcellular localization of only DAF-16a2, but not other isoforms such as DAF-16b and DAF-16df \[[@bib30]\]. A previous report showed the different effects of DAF-16a, including the DAF-16a2 isoform, on *sod-3* and *-5* expression \[[@bib30]\]. We might be unable to observe the nuclear localization, which indicates activity of not DAF-16a but other DAF-16 isoforms, such as DAF-16b and DAF-16df, under more stressful conditions. However, this suggests a need to examine the roles of factors other than DAF-16a, including the DAF-16b and DAF-16df isoforms, in the systematic regulation of *sod* expression under conditions of more severe intracellular oxidative stress.
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